Study Design to Assess Anti-TIGIT Mab Combination with Dostarlimab vs Pembrolizumab or Dostarlimab Monotherapy in NSCLC

Spigel, DR; Cho, BC; Reck, M; Nakagawa, K; Wimalasundera, S; Parkhomenko, E; Parasrampuria, R; Parker, L; Khaled, A; Satouchi, M

JOURNAL OF THORACIC ONCOLOGY, 2023; 18 (11): S319

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索